Yann Mazabraud
Corporate Officer/Principal chez RHYTHM PHARMACEUTICALS, INC.
Fortune : 1 M $ au 30/04/2024
Provenance du réseau au premier degré de Yann Mazabraud
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
17
| Subsidiary | Medical Specialties | 17 |
| Public Company | Biotechnology | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yann Mazabraud via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| VERICEL CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Biotechnology | Corporate Officer/Principal General Counsel Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree Graduate Degree | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | President Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer General Counsel | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Founder Private Equity Analyst | |
| UMass Chan Medical School | College/University | Doctorate Degree Doctorate Degree | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Edinburgh | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
NovaSom, Inc.
 NovaSom, Inc. Medical/Nursing ServicesHealth Services NovaSom, Inc. provides diagnostic services. It offers Obstructive Sleep Apnea home testing, with the AccuSom home sleep test, the only supported home sleep test that provides continuous patient support and next-day test results. The company was founded in 1992 and is headquartered in Glen Burnie, MD. | Medical/Nursing Services | Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| TAMDA LTD | Beverages: Non-Alcoholic | Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 39 |
| France | 4 |
| Royaume-Uni | 4 |
| Suède | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 241 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 81 |
| Undergraduate Degree | 40 |
| Chief Tech/Sci/R&D Officer | 32 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Todd Foley | 38 |
| Otello Stampacchia | 37 |
| Mette Agger | 30 |
| Anne VanLent | 23 |
| Eran Nadav | 21 |
| Christophe Jean | 19 |
| David Meeker | 19 |
| Camille Bedrosian | 18 |
| Irina Antonijevic | 17 |
| Richard Peters | 16 |
| David McGirr | 16 |
| Lynn Tetrault | 15 |
| Stuart Arbuckle | 10 |
| John Koconis | 10 |
- Bourse
- Insiders
- Yann Mazabraud
- Connexions Sociétés